Efficacy of Amikacin and Imipenem Against Multi-Drug Resistant Gram-Negative Bacteria Isolated from Wound Infections, Egypt

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 105

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJMM-17-2_011

تاریخ نمایه سازی: 18 تیر 1402

Abstract:

Background and Aim: Gram-negative pathogens are considered the common cause of wound infections associated with increased mortality and morbidity rates. Antibiotics combination has been used to overcome this problem. In this study, we identify Gram-negative pathogens found in wound infections and assess the in-vitro efficacy of a combination of amikacin and imipenem against the resistant isolated pathogens. Materials and Methods: One hundered fifty gram-negative bacteria were collected from two hundered patients suffering from different wound infections. Patients attended Minia University Hospitals,Egypt at period from January ۲۰۱۹- January ۲۰۲۰ and they were  followed up periodically as a routine work in the hospitals. Swabs streaked on various media as Nutrient agar, MacConkey agar, Eosin methylene blue agar and cetrimide agar. The antimicrobial susceptibility of the identified pathogens was tested using the Kirby-Bauer method. Conventional PCR was used to detect the prevalence of bla-IMP and AAC (۶’)-Ib genes. The effect of the tested combination was assessed by checkerboard technique and time-killing assay. Results: Escherichia coli ۳۸.۶% was the most common isolated pathogen, followed by Proteus spp ۳۰%, P. aeruginosa ۲۱.۴%, Klebsiella spp. ۵.۷%, and Acinetobacter baumannii ۴.۳%. The isolates were completely resistant to Ampicillin/sulbactam, Amoxicillin/clavulanic, Cephalothin, Cefadroxil, Ciprofloxacin, Ceftazidime and Ofloxacin. Bla-IMP was detected in all Klebsiella spp., E. coli (۸۵.۲%), A. baumannii (۶۶.۷%), Proteus spp. (۳۸.۱%) and P. aeruginosa (۳۳.۳۵%). aac(۶’)-Ib was detected among E. coli, P. aeruginosa and Proteus spp. The Checkerboard test showed a significant decrease in bacterial count in the presence of combination indicating a synergistic effect with FICIs ≤۰.۵. Time-kill assay showed a significant decrease in the bacterial count after ۱۲h. Conclusion: The studied combinations of antibiotics showed synergistic effects against the tested Gram-negative bacteria which can help in the control and treatment of serious wound infections.

Authors

Sara Mahmoud Farhan

Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia, Egypt

Rehab Mahmoud Abd El-Baky

Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia, Egypt

Salah aldin Mohammad Abdalla

Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismalia, Egypt

Ahmed Osama El-Gendy

Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

Ahmed Farag Azmy

Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. ...
  • Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, ...
  • Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. ...
  • Elgharably A, Gomaa AI, Crossey MME, Norsworthy PJ, Waked I, ...
  • Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, ...
  • Lu M, Li J, Rupp LB, Zhou Y, Holmberg SD, ...
  • de Oliveria Andrade LJ, D'Oliveira A, Melo RC, De Souza ...
  • Bennett JE, Dolin R, Blaser MJ. Mandell, douglas, and bennett's ...
  • Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. Direct acting ...
  • Ji F, Wei B, Yeo YH, Ogawa E, Zou B, ...
  • Wei B, Ji F, Yeo YH, Ogawa E, Stave CD, ...
  • Liang TJ, Ghany MG. Current and future therapies for hepatitis ...
  • Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Bartolomé J, ...
  • Hetta HF, Mehta MJ, Shata MTM. Gut immune response in ...
  • Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, ...
  • Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, ...
  • Antonelli A, Ferrari SM, Ruffilli I, Fallahi P. Cytokines and ...
  • Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, ...
  • Grakoui A, Shoukry NH, Woollard DJ, Han J-H, Hanson HL, ...
  • Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, ...
  • Gad YZ, Mouas N, Abdel-Aziz A, Abousmra N, Elhadidy M. ...
  • Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, ...
  • Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, ...
  • Scheel TKH, Rice CM. Understanding the hepatitis C virus life ...
  • Abd Alla MDA, El Awady MK. Hepatitis C Virus RNA ...
  • Hanno AFF, Mohiedeen KM, Alshayeb AF, Deghedy A. HCV RNA ...
  • Pawełczyk A, Kubisa N, Jabłońska J, Bukowska-Ośko I, Caraballo Cortes ...
  • De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh ...
  • Pham TNQ, Coffin CS, Michalak TI. Occult hepatitis C virus ...
  • Aboalam H, Rashed H-A, Mekky M, Nafeh H, Osman O. ...
  • Yousif MM, Fakhr AE, Morad EA, Kelani H, Hamed EF, ...
  • Abu Khadr NA, Nouh HH, Hanafi NF, Asser SL, Hussain ...
  • Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V. ...
  • Cavalheiro Nde P, Filgueiras TC, Melo CE, Morimitsu SR, de ...
  • Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, ...
  • Bernardin F, Tobler L, Walsh I, Williams JD, Busch M, ...
  • Rahman MZ, Ahmed DS, Masud H, Parveen S, Rahman MA, ...
  • Sood A, Midha V, Mehta V, Sharma S, Mittal R, ...
  • نمایش کامل مراجع